Published by Josh White on 22nd November 2022
(Sharecast News) - Gene and cell therapy specialist Oxford Biomedica announced the appointment of Dr Frank Mathias as its new chief executive officer and a board director on Tuesday, effective from March.
URL: http://www.digitallook.com/dl/news/story/33126332/...